| Literature DB >> 30108989 |
Itamar Luís Gonçalves1, Liliana Rockenbach1, Gustavo Machado das Neves1, Gabriela Göethel2, Fabiana Nascimento1, Luciano Porto Kagami1, Fabrício Figueiró3, Gabriel Oliveira de Azambuja1, Amanda de Fraga Dias3, Andressa Amaro3, Lauro Mera de Souza4, Ivan da Rocha Pitta5, Daiana Silva Avila6, Daniel Fábio Kawano7, Solange Cristina Garcia2, Ana Maria Oliveira Battastini3, Vera Lucia Eifler-Lima1.
Abstract
An original and focused library of two sets of dihydropyrimidin-2-thiones (DHPMs) substituted with N-1 aryl groups derived from monastrol was designed and synthesized in order to discover a more effective Eg5 ligand than the template. Based on molecular docking studies, four ligands were selected to perform pharmacological investigations against two glioma cell lines. The results led to the discovery of two original compounds, called 20h and 20e, with an anti-proliferative effects, achieving IC50 values of about half that of the IC50 of monastrol in both cell lines. As with monastrol, flow cytometry analyses showed that the 20e and 20h compounds induced cell cycle arrest in the G2/M phase, and immunocytochemistry essays revealed the formation of monopolar spindles due to Eg5 inhibition without any toxicity to Caenorhabditis elegans.Entities:
Year: 2018 PMID: 30108989 PMCID: PMC6072436 DOI: 10.1039/c8md00095f
Source DB: PubMed Journal: Medchemcomm ISSN: 2040-2503 Impact factor: 3.597